robert kennedy glp 1 RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals RFK Jr. Says People Should

Chronic diseases require continuation strategies, not sudden withdrawal

Lifevantage (NASDAQ:LFVN) executives outlined the companys business model, product portfolio, financial profile, and growth priorities during a recent investor presentation and Q&A, highlighting a subscription-heavy revenue base, expanding product categories, and a balanced approach to capital

Managing joint pain or headaches while on tirzepatide requires understanding how nonsteroidal anti-inflammatory drugs interact with your GLP-1 therapy

However, that is not the reality: even diabetic patients treated with GLP-1 RAs are more likely to stop them than other second-line anti-diabetic medicines.3 That study didnt report why 50% of diabetics on GLP-1 RAs discontinued them, but gastrointestinal (GI) adverse events were a suggested cause.3 Adverse events are just one of a number of reasons that people stop using these drugs, as follows.

Learn what sleep apnea patients should know about GLP-1 weight loss medications, treatment expectations, and when CPAP may still be needed.

Discover if berberine can be a substitute for Ozempic when it comes to weight loss